Not Tagged
pfizer
['lung', 'nsclc', 'pharos', 'sclc', 'pfizer']
we re unveiling the first detailed results from the pharos study, evaluating a molecular targeted combination therapy in braf v600e-mutant metastatic non-small cell lung cancer (#nsclc). abstract 9018 will be presented at #asco23 today, june 4. 
News and information for healthcare professionals about Pfizer’s presence at scientific congresses. Please read: https://t.co/xwMAFDI5j5